CERo Therapeutics Holdings Inc

États‑Unis d’Amérique

Commandez votre montre hebdomadaire CERo Therapeutics Holdings Inc
Quantité totale PI 20
Rang # Quantité totale PI 76 105
Note d'activité PI 2,1/5.0    16
Rang # Activité PI 52 519
Symbole boursier CEROW (nasdaq)

Brevets

Marques

14 0
6 0
0 0
0
 
Dernier brevet 2025 - Chimeric tim4 receptors and uses...
Premier brevet 2017 - Chimeric engulfment receptor mol...

Derniers inventions, produits et services

2025 Invention Chimeric tim4 receptors and uses thereof. The present disclosure relates to chimeric Tim4 recept...
Invention Chimeric tim receptors and uses thereof. The present disclosure relates to chimeric Tim receptor...
2024 Invention Anti-cd72 chimeric receptors and uses thereof. The present disclosure relates to compositions an...
2023 Invention Chimeric engulfment receptor molecules. The present disclosure relates to chimeric engulfment re...
Invention Chimeric engulfment receptor molecules and methods of use. The present disclosure relates to chi...
2021 Invention Compositions and methods for treating cancer with chimeric tim receptors in combination with inhi...
Invention Chimeric tim receptors and uses thereof. The present disclosure relates to chimeric Tim receptors...
Invention Anti-cd72 chimeric receptors and uses thereof. The present disclosure relates to compositions and...
Invention Chimeric engulfment receptor molecules. The present disclosure relates to chimeric engulfment rec...
Invention Bivalent chimeric engulfment receptors and uses thereof. The present disclosure relates to bival...
2019 Invention Chimeric tim4 receptors and uses thereof. The present disclosure relates to chimeric Tim4 recepto...
Invention Expression vectors for chimeric engulfment receptors, genetically modified host cells, and uses t...
Invention Cellular immunotherapy compositions and uses thereof. The present disclosure relates to cellular ...
Invention Chimeric engulfment receptors and uses thereof for neurodegenerative diseases. The present discl...
2018 Invention Chimeric engulfment receptor molecules and methods of use. The present disclosure relates to chim...